Page 17 - Cell Stem News Today

According to a recent study published in Cell Stem Cell, researchers have found that the Parkinson’s disease drug ropinirole may be effective in slowing

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing symptoms and providing supportive care. Reporting June 1 in the journal Cell Stem Cell, researchers from Japan show in an early clinical trial that the Parkinson’s disease drug ropinirole is safe to use in ALS patients and delayed disease progression by 27.9 weeks on a...

Yale researchers investigate a multi-tasking protein, find a new way to study a key area of the brain, and earn honors for innovative applied mathematics.

Amyotrophic lateral sclerosis is an incurable disease that causes people to gradually lose control of their muscles.

Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles.

{"desktop":[{"injectionEnabled":false,"componentType":"gpt","targeting":{"index":-1,"hivis":"n"},"referenceNode":"header","hideOnSensitiveArticle":true,"hideOnFirstPageView":true,"relativePos":"after","name":"div-gpt-ad-oop-slot","isOOP":true,"type":"outOfPage"},{"componentType":"gpt",&quo...

ALS patients treated using ropinirole showed slower rates of decline in mobility, muscle strength, and lung function, and longer disease-progression-free survival.

Veronica smiledBBC News World4 hours agophoto credit, Good picturesimage caption, The stomach is considered the black box of human development because it

Researchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.